Fülöp Tamas, Dupuis Gilles, Witkowski Jacek M, Larbi Anis
Research Center on Aging, Graduate Program in Immunology, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada.
Department of Biochemistry, Graduate Program in Immunology, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada.
Rev Invest Clin. 2016 Mar-Apr;68(2):84-91.
Aging is a complex phenomenon leading to numerous changes in the physiological systems of the body. One of the most important changes, called immunosenescence, occurs in the immune system. Immunosenescence covers changes in the innate and the adaptive immune systems and is associated with a low-grade inflammation called inflammaging. Aging, likely via inflammaging, is also associated with the emergence of chronic diseases including cardiovascular and neurodegenerative diseases, cancer, and diabetes mellitus type 2. The origin of this inflammaging is not known with certainty, but several concurrent contributing factors have been suggested, such as aging-associated changes in the innate and adaptive immune response, chronic antigenic stimulation, the appearance of endogenous macromolecular changes, and the presence of senescent cells exhibiting a senescence-associated secretory phenotype. A better understanding of the multiple biological phenomena leading to these diseases via the immunosenescence associated with inflammaging provides a powerful target for interventions to increase the healthspan of elderly subjects.
衰老 是一种复杂的现象,会导致身体生理系统发生众多变化。其中最重要的变化之一发生在免疫系统,即所谓的免疫衰老。免疫衰老涵盖先天性和适应性免疫系统的变化,并与一种称为炎症衰老的低度炎症相关。衰老可能通过炎症衰老,还与包括心血管疾病、神经退行性疾病、癌症和2型糖尿病在内的慢性疾病的出现有关。这种炎症衰老的起源尚不确定,但已提出了几个共同的促成因素,如先天性和适应性免疫反应中与衰老相关的变化、慢性抗原刺激、内源性大分子变化的出现,以及表现出衰老相关分泌表型的衰老细胞的存在。通过与炎症衰老相关的免疫衰老,更好地理解导致这些疾病的多种生物学现象,为延长老年受试者健康寿命的干预措施提供了一个有力的靶点。